Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2018

May 8, 2018

29777_dirs_2018-05-08_4bf0db48-c825-4786-847d-6ba046111586.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2018-05-04

Reporting Person: Bracken Sharon J (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-05-04 Common shares without par value S 300 $58.56 Disposed 43990 Direct
2018-05-04 Common shares without par value S 400 $58.5601 Disposed 43590 Direct
2018-05-04 Common shares without par value S 450 $58.5610 Disposed 43140 Direct
2018-05-04 Common shares without par value S 1000 $58.5650 Disposed 42140 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 747 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of May 8, 2018.